# Microvi Biotech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/microvi-biotech

- Industry: Biotechnology
- Headquarters: Union City, US
- Website: www.microvibiotech.com
- Total disclosed funding: $1M
- Latest round: Series A (Aug 27, 2009)
- Investors on record: 1

## About

Microvi Biotech Inc. is a biotechnology firm that specializes in innovative solutions to enhance microbiological applications across various industry sectors, focusing on sustainability and efficiency.Microvi Biotech Inc. was founded in 2004 and is headquartered in Union City, US. The company develops advanced biotechnological products aimed at optimizing microbial processes. In January 2015, Microvi Biotech Inc. raised USD 1.00 mn in a SERIES A funding round led by Battery Ventures, bringing the total amount raised to USD 1.00 mn. The CEO of the company is Fatemeh Shirazi.Microvi Biotech Inc. specializes in the development and provision of innovative biotechnological solutions aimed at enhancing microbiological applications across various industries. The company focuses on advanced products designed to optimize microbial processes, improve bioavailability, and facilitate efficient bioconversion. These offerings address critical challenges in agriculture, pharmaceuticals, and environmental management, contributing to sustainable practices and improved outcomes. Core products include proprietary formulations leveraging unique microbial strains for enhanced efficacy, targeting both research environments and industrial clients, with markets extending to North America and Europe.Microvi Biotech Inc.'s revenue model is based on direct sales to commercial clients and partnerships with distributors. Transactions typically involve bulk orders of their flagship microbial products, tailored to the specific needs of various industries. Clients can enter into subscription agreements for ongoing supply and support services. The company's revenue generation is further bolstered by collaborations with research institutions and enterprises seeking specialized solutions in bioconversion and microbial enhancement.Microvi Biotech Inc. plans to leverage its recent SERIES A funding to support the development of new products aimed at enhancing microbial performance, with a focus on increasing market penetration in North America and Europe. The company is actively designing upcoming products that address demands in agriculture and pharmaceuticals, with anticipated releases in the next 12 to 18 months. Furthermore, the company aims to expand into additional markets in Asia and South America by 2025, utilizing the funds raised to support these strategic initiatives.

## Funding rounds

- Series A, Aug 27, 2009, $1M — Battery Ventures

## Investors

- Battery Ventures (https://capitalatlas.ai/funds/battery-ventures) — Series A